253 related articles for article (PubMed ID: 29353083)
21. Na
Araste F; Abnous K; Hashemi M; Dehshahri A; Detampel P; Alibolandi M; Ramezani M
Eur J Pharm Sci; 2020 Feb; 143():105207. PubMed ID: 31870814
[TBL] [Abstract][Full Text] [Related]
22. NIR-Light-Triggered Anticancer Strategy for Dual-Modality Imaging-Guided Combination Therapy via a Bioinspired Hybrid PLGA Nanoplatform.
Shen X; Li T; Chen Z; Xie X; Zhang H; Feng Y; Li S; Qin X; Yang H; Wu C; Zheng C; Zhu J; You F; Liu Y
Mol Pharm; 2019 Mar; 16(3):1367-1384. PubMed ID: 30776896
[TBL] [Abstract][Full Text] [Related]
23. A smart, phase transitional and injectable DOX/PLGA-Fe implant for magnetic-hyperthermia-induced synergistic tumor eradication.
Gao W; Zheng Y; Wang R; Chen H; Cai X; Lu G; Chu L; Xu C; Zhang N; Wang Z; Ran H; Li P; Yang C; Mei Z; Song J
Acta Biomater; 2016 Jan; 29():298-306. PubMed ID: 26432438
[TBL] [Abstract][Full Text] [Related]
24. Self-assembled micelles based on Chondroitin sulfate/poly (d,l-lactideco-glycolide) block copolymers for doxorubicin delivery.
Zhang H; Xu J; Xing L; Ji J; Yu A; Zhai G
J Colloid Interface Sci; 2017 Apr; 492():101-111. PubMed ID: 28073063
[TBL] [Abstract][Full Text] [Related]
25. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
Zhang X; Li J; Yan M
Drug Dev Ind Pharm; 2016 Oct; 42(10):1590-9. PubMed ID: 26942448
[TBL] [Abstract][Full Text] [Related]
26. Ultrasound-triggered PLGA microparticle destruction and degradation for controlled delivery of local cytotoxicity and drug release.
Jang KW; Seol D; Ding L; Heo DN; Lee SJ; Martin JA; Kwon IK
Int J Biol Macromol; 2018 Jan; 106():1211-1217. PubMed ID: 28851638
[TBL] [Abstract][Full Text] [Related]
27. pH-Triggered Surface Charge Reversed Nanoparticle with Active Targeting To Enhance the Antitumor Activity of Doxorubicin.
Du JB; Cheng Y; Teng ZH; Huan ML; Liu M; Cui H; Zhang BL; Zhou SY
Mol Pharm; 2016 May; 13(5):1711-22. PubMed ID: 26998644
[TBL] [Abstract][Full Text] [Related]
28. Improvement of the Antitumor Efficacy of Intratumoral Administration of Cucurbitacin Poly(Lactic-co-Glycolic Acid) Microspheres Incorporated in In Situ-Forming Sucrose Acetate Isobutyrate Depots.
Wang JW; Xu JH; Li J; Zhao MH; Zhang HF; Liu DC; Zhou X; Xu H
J Pharm Sci; 2016 Jan; 105(1):205-11. PubMed ID: 26566075
[TBL] [Abstract][Full Text] [Related]
29. Hyaluronic acid/doxorubicin nanoassembly-releasing microspheres for the transarterial chemoembolization of a liver tumor.
Lee SY; Choi JW; Lee JY; Kim DD; Kim HC; Cho HJ
Drug Deliv; 2018 Nov; 25(1):1472-1483. PubMed ID: 29909706
[TBL] [Abstract][Full Text] [Related]
30. Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers.
Wohlfart S; Khalansky AS; Gelperina S; Maksimenko O; Bernreuther C; Glatzel M; Kreuter J
PLoS One; 2011 May; 6(5):e19121. PubMed ID: 21573151
[TBL] [Abstract][Full Text] [Related]
31. Intratumoral thermo-chemotherapeutic alginate hydrogel containing doxorubicin loaded PLGA nanoparticle and heating agent.
Tsai LH; Young TH; Yen CH; Yao WC; Chang CH
Int J Biol Macromol; 2023 Nov; 251():126221. PubMed ID: 37572819
[TBL] [Abstract][Full Text] [Related]
32. Magnetic field activated drug release system based on magnetic PLGA microspheres for chemo-thermal therapy.
Fang K; Song L; Gu Z; Yang F; Zhang Y; Gu N
Colloids Surf B Biointerfaces; 2015 Dec; 136():712-20. PubMed ID: 26513754
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.
Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M
Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991
[TBL] [Abstract][Full Text] [Related]
34. PEGylated-PLGA Nanoparticles Coated with pH-Responsive Tannic Acid-Fe(III) Complexes for Reduced Premature Doxorubicin Release and Enhanced Targeting in Breast Cancer.
Hu F; Zhang R; Guo W; Yan T; He X; Hu F; Ren F; Ma X; Lei J; Zheng W
Mol Pharm; 2021 Jun; 18(6):2161-2173. PubMed ID: 32515968
[TBL] [Abstract][Full Text] [Related]
35. Biotin-Conjugated Multilayer Poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin.
Dai Y; Xing H; Song F; Yang Y; Qiu Z; Lu X; Liu Q; Ren S; Chen X; Li N
J Pharm Sci; 2016 Sep; 105(9):2949-2958. PubMed ID: 27209461
[TBL] [Abstract][Full Text] [Related]
36. Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations.
Zhang Z; Wang X; Li B; Hou Y; Yang J; Yi L
Drug Deliv; 2018 Nov; 25(1):166-177. PubMed ID: 29299936
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic efficacy of novel microwave-sensitized mPEG-PLGA@ZrO
Mao J; Tang S; Hong D; Zhao F; Niu M; Han X; Qi J; Bao H; Jiang Y; Fu C; Long D; Meng X; Su H
Nanoscale; 2017 Mar; 9(10):3429-3439. PubMed ID: 28233003
[TBL] [Abstract][Full Text] [Related]
38. PLGA based particles as "drug reservoir" for antitumor drug delivery: characterization and cytotoxicity studies.
Chronopoulou L; Domenici F; Giantulli S; Brasili F; D'Errico C; Tsaouli G; Tortorella E; Bordi F; Morrone S; Palocci C; Silvestri I
Colloids Surf B Biointerfaces; 2019 Aug; 180():495-502. PubMed ID: 31103709
[TBL] [Abstract][Full Text] [Related]
39. Verteporfin-Loaded Polymeric Microparticles for Intratumoral Treatment of Brain Cancer.
Shah SR; Kim J; Schiapparelli P; Vazquez-Ramos CA; Martinez-Gutierrez JC; Ruiz-Valls A; Inman K; Shamul JG; Green JJ; Quinones-Hinojosa A
Mol Pharm; 2019 Apr; 16(4):1433-1443. PubMed ID: 30803231
[TBL] [Abstract][Full Text] [Related]
40. The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation.
Yu KF; Zhang WQ; Luo LM; Song P; Li D; Du R; Ren W; Huang D; Lu WL; Zhang X; Zhang Q
Int J Nanomedicine; 2013; 8():2473-85. PubMed ID: 23885174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]